eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 4,247.83%1.91B | -7.16%8.61B | 1.47B | -46M | -3.81%9.27B | -8.40%9.64B | 41.84%10.52B | -3.85%7.42B | 39.08%7.72B | -24.83%5.55B |
Net income from continuing operations | ---- | 8.57%5.5B | ---- | ---- | -36.49%5.06B | 28.07%7.97B | -49.38%6.22B | 346.41%12.29B | -36.04%2.75B | -48.84%4.31B |
Operating gains losses | ---- | -103.17%-6M | ---- | ---- | 147.13%189M | -464.79%-401M | 99.02%-71M | -3,106.19%-7.25B | 77.03%-226M | -926.89%-984M |
Depreciation and amortization | ---- | -19.03%3.59B | ---- | ---- | 42.50%4.43B | -7.25%3.11B | -8.72%3.35B | -50.69%3.67B | 73.99%7.45B | 16.09%4.28B |
Deferred tax | ---- | 34.96%-802M | ---- | ---- | -133.08%-1.23B | -48.60%-529M | -61.09%-356M | 87.53%-221M | -143.74%-1.77B | 20.02%-727M |
Other non cash items | ---- | -55.56%136M | ---- | ---- | 29.66%306M | 7,766.67%236M | 100.48%3M | -257.47%-622M | -179.82%-174M | 104.95%218M |
Change In working capital | ---- | -248.91%-615M | ---- | ---- | 152.02%413M | -156.35%-794M | 533.54%1.41B | 22.43%-325M | 67.27%-419M | -970.75%-1.28B |
-Change in receivables | ---- | 94.07%-28M | ---- | ---- | 5.60%-472M | -370.27%-500M | 238.06%185M | 71.00%-134M | -1,220.00%-462M | 93.38%-35M |
-Change in inventory | ---- | 44.92%-477M | ---- | ---- | 5.66%-866M | -157.14%-918M | 39.80%-357M | -8.41%-593M | 21.97%-547M | -386.81%-701M |
-Change in payables and accrued expense | ---- | 205.81%789M | ---- | ---- | -24.12%258M | -24.61%340M | 424.42%451M | -49.11%86M | -37.41%169M | -53.21%270M |
-Change in other working capital | ---- | -160.21%-899M | ---- | ---- | 425.70%1.49B | -74.87%284M | 257.59%1.13B | -24.94%316M | 151.72%421M | -434.98%-814M |
Cash from discontinued investing activities | 38.06%185M | -51.98%474M | 134M | 11.15%987M | 888M | |||||
Operating cash flow | 2,278.41%2.09B | -11.47%9.08B | --1.34B | --88M | -2.55%10.26B | 0.04%10.53B | 41.84%10.52B | -3.85%7.42B | 39.08%7.72B | -24.83%5.55B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -111.29%-767M | 13.17%-4.3B | -3.05B | -363M | -133.82%-4.95B | 70.99%-2.12B | -301.66%-7.3B | 405.92%3.62B | 90.81%-1.18B | -344.27%-12.87B |
Net PPE purchase and sale | ---- | 17.39%-1.73B | ---- | ---- | -175.10%-2.1B | 44.18%-763M | -17.34%-1.37B | -106.93%-1.17B | -402.69%-563M | 113.09%186M |
Net business purchase and sale | ---- | 3.92%-2.52B | ---- | ---- | -96.04%-2.63B | 75.86%-1.34B | -210.29%-5.55B | 1,131.56%5.03B | 96.20%-488M | -1,017.03%-12.86B |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | -127.01%-311M | -260.53%-137M | 72.26%-38M | -124.59%-137M |
Net other investing changes | -111.29%-767M | 82.14%-40M | --322M | ---363M | -1,500.00%-224M | 79.41%-14M | 39.82%-68M | -20.21%-113M | -62.07%-94M | 77.95%-58M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -108.60%-776M | 28.92%-4.41B | ---3.04B | ---372M | -198.80%-6.2B | 71.57%-2.08B | -301.66%-7.3B | 451.70%3.62B | 92.01%-1.03B | -2,114.40%-12.87B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -176.84%-584M | 28.54%-5.75B | -671M | 760M | -38.59%-8.05B | 17.70%-5.81B | -8.80%-7.06B | -54.66%-6.49B | -206.58%-4.19B | 149.78%3.93B |
Net issuance payments of debt | ---- | 71.50%-894M | ---- | ---- | -154.42%-3.14B | 56.03%-1.23B | -48.75%-2.8B | -283.91%-1.89B | -105.63%-491M | 479.71%8.72B |
Net common stock issuance | ---- | 71.11%-115M | ---- | ---- | -28.80%-398M | -57.65%-309M | 68.34%-196M | -504.58%-619M | 116.56%153M | 49.86%-924M |
Cash dividends paid | ---- | -5.61%-4.7B | ---- | ---- | -6.86%-4.45B | -3.99%-4.17B | -1.80%-4.01B | -2.69%-3.94B | -1.62%-3.83B | -1.70%-3.77B |
Net other financing activities | -176.84%-584M | 35.59%-38M | ---791M | --760M | 39.18%-59M | -102.08%-97M | -9.09%-48M | -109.52%-44M | 76.92%-21M | -75.00%-91M |
Cash from discontinued financing activities | -8M | -200.00%-12M | 0 | 71.43%-4M | -14M | |||||
Financing cash flow | -177.89%-592M | 28.43%-5.76B | ---671M | --760M | -38.33%-8.05B | 17.50%-5.82B | -8.80%-7.06B | -54.66%-6.49B | -206.58%-4.19B | 149.78%3.93B |
Net cash flow | ||||||||||
Beginning cash position | -14.57%7.44B | -31.61%8.71B | --9.18B | --8.71B | 26.12%12.74B | -27.43%10.1B | 47.61%13.92B | 36.13%9.43B | -32.86%6.93B | 0.41%10.32B |
Current changes in cash | 19.75%570M | 68.55%-1.26B | ---2.38B | --476M | -251.86%-3.99B | 168.63%2.63B | -184.18%-3.83B | 82.59%4.55B | 173.52%2.49B | -3,023.28%-3.39B |
Effect of exchange rate changes | -300.00%-20M | 59.38%-13M | ---9M | ---5M | -500.00%-32M | -46.67%8M | 123.44%15M | -811.11%-64M | 800.00%9M | 101.35%1M |
End cash Position | -12.96%7.99B | -14.57%7.44B | --6.8B | --9.18B | -31.61%8.71B | 26.12%12.74B | -27.43%10.1B | 47.61%13.92B | 36.13%9.43B | -32.86%6.93B |
Free cash flow | 2,278.41%2.09B | -19.94%5.89B | ---551M | --88M | -12.72%7.35B | -0.66%8.42B | 58.93%8.48B | -10.00%5.34B | 66.05%5.93B | -34.17%3.57B |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion |